Sofina Ventures exits 1.28% of Honasa Consumer in ₹177 Cr bulk deal at ₹424/share
Belgian investor Sofina Ventures offloaded 41.78 Lakh shares of Mamaearth parent Honasa Consumer via a ₹177.2 Cr bulk deal, even as the stock is up 42% YTD. The exit comes amid Honasa's 'Honasa 3.0' reset and its ₹135 Cr Fluence Pharma buy targeting ₹5,500 Cr revenue and 15%+ EBITDA by FY31.
What happened
Sofina Ventures sold a 1.28% stake in Honasa Consumer (Mamaearth parent) via a ₹177 Cr bulk deal at ₹424/share, amid Honasa's 'Honasa 3.0' strategy and recent
Key facts
- ₹177.2 Cr deal size
- 41.78 Lakh shares
- ₹424.07 per share
- 1.28% stake
- 42% YTD stock gain
- ₹135 Cr Fluence acquisition
- 58% stake in Fluence
- ₹5,500 Cr FY31 revenue target
- 15%+ EBITDA target
Why this matters
Sofina's clean exit signals early-investor rotation is open, creating room for strategic or long-only entrants as Honasa pivots via the ₹135 Cr Fluence Pharma acquisition.
What to watch
- Q3FY26 results — BPC volume growth and EBITDA margin trajectory
- Fluence Pharma deal closure and revenue contribution guidance
- Any further bulk/block deal prints above 0.5% stake
- Brokerage rating revisions post the bulk deal
- Promoter pledge or insider buying disclosures
- Mamaearth offline distribution expansion metrics
- Track Sofina's residual holding disclosure in next shareholding pattern
- Monitor mutual fund and FII buy-side in the bulk deal counterparty list
- Watch for management commentary on Fluence Pharma integration timelines
- Scan for follow-on block deals from other early backers (Stellaris, Fireside)